QMS Medical Allied Services IPO is a Fixed Price listing on NSE EMERGE exchange. The company is based in Mumbai and caters to Healthcare sector. First Overseas Capital is the merchant banker of QMS Medical Allied Services IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 29th January 2021.
QMS Medical Allied Services IPO posted revenues of ₹ 147.74 crores and PAT of ₹ 10.71 crores in FY00 on annualised basis.Financial results of QMS Medical Allied Services IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Financials | FY22 | FY21 | FY20 | ||
---|---|---|---|---|---|
Balance Sheet
|
|||||
Assets | 82.67 | 60.37 | 33.48 | ||
Net Worth | 31.03 | 20.32 | 9.41 | ||
Total Debt | 31.98 | 19.60 | 11.60 | ||
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
146.32 | 122.03 | 72.74 | ||
EBITDA
EBITDA on annualised basis |
17.74 | 16.95 | 9.61 | ||
PAT
PAT on annualised basis |
10.71 | 10.92 | 6.35 |
QMS Medical Allied Services IPO PAT Margin is 7.32 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows QMS Medical Allied Services IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
Particulars | FY22 | FY21 | FY20 |
---|---|---|---|
EBITDA Margin (%) | 12.12 | 13.89 | 13.21 |
PAT Margin (%) | 7.32 | 8.95 | 8.73 |
EPS (₹) | 7.11 | 7.25 | 4.22 |
ROE (%) | 34.51 | 53.74 | 67.48 |
ROCE (%) | [●] | [●] | [●] |
ROA (%) | 12.96 | 18.09 | 18.97 |
Debt to Equity | 1.03 | 0.96 | 1.23 |
The market Capitalisation of QMS Medical Allied Services IPO is ₹ 215.99 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The QMS Medical Allied Services IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows QMS Medical Allied Services IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of QMS Medical Allied Services IPO is ₹ 215.99 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The QMS Medical Allied Services IPO has a Price-to-Earnings (PE) ratio of 20.10 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
QMS Medical Allied Services IPO reported revenue of ₹ 147.74 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from QMS Medical Allied Services IPO provide insights into sales growth, market demand, and business scalability.
QMS Medical Allied Services recorded an EBITDA of ₹ 17.74 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
QMS Medical Allied Services Profit After Tax (PAT) is ₹ 10.71 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
QMS Medical Allied Services operates in Healthcare and Distribution Of Medical Products. The Issue is listed on NSE EMERGE in Oct, 2022. QMS Medical Allied Services IPO size was 56.87 with Issue price of 121.00 .
Merchant Banker(s) of QMS Medical Allied Services IPO: First Overseas Capital Limited
QMS Medical Allied Services IPO subscription was 0.88 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
QMS Medical Allied Services IPO listed at a listing price of 134.40 against the offer price of 121.00.
The current market price of QMS Medical Allied Services is 87.20.
Why Us?